Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology
Transmission-blocking vaccines (TBV) target the sexual-stages of the malaria parasite in the mosquito midgut and are widely considered to be an essential tool for malaria elimination. High-titer functional antibodies are required against target antigens to achieve effective transmission-blocking act...
Main Authors: | Li, Yuanyuan, Leneghan, Darren B., Miura, Kazutoyo, Nikolaeva, Daria, Brian, Iona J., Dicks, Matthew D. J., Fyfe, Alex J., Zakutansky, Sarah E., de Cassan, Simone, Long, Carole A., Draper, Simon J., Hill, Adrian V. S., Hill, Fergal, Biswas, Sumi |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705524/ |
Similar Items
-
A Viral Vectored Prime-Boost Immunization Regime Targeting the Malaria Pfs25 Antigen Induces Transmission-Blocking Activity
by: Goodman, Anna L., et al.
Published: (2011) -
A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults
by: Minhinnick, Alice, et al.
Published: (2016) -
Pengisytiharan PFS pencapaian bersejarah
by: Berita Harian, Mohamed Basyir
Published: (2018) -
New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission
by: Kathleen A. McGuire, et al.
Published: (2017-06-01) -
Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates
by: Lee, Shwu-Maan, et al.
Published: (2016)